샘플 요청 목록

 카트 문의
시장보고서
상품코드
1737402

세계의 좌골신경통 치료 시장

Sciatica Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 380 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 좌골신경통 치료 시장은 2030년까지 8억 4,800만 달러에 달할 전망

2024년에 7억 3,570만 달러로 추정되는 세계의 좌골신경통 치료 시장은 2030년에는 8억 4,800만 달러에 달하며, 분석 기간인 2024-2030년의 CAGR은 2.4%로 성장할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 급성 좌골신경통 치료는 CAGR 2.7%를 기록하며, 분석 기간 종료시에는 5억 240만 달러에 달할 것으로 예측됩니다. 만성 좌골신경통 치료 분야의 성장률은 분석 기간 중 CAGR 1.6%로 추정됩니다.

미국 시장은 2억 50만 달러로 추정, 중국은 CAGR 4.7%로 성장 예측

미국의 좌골신경통 치료 시장은 2024년에 2억 50만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR을 4.7%로 2030년까지 1억 6,270만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 0.9%와 1.8%로 예측됩니다. 유럽에서는 독일이 CAGR 1.3%로 성장할 것으로 예측됩니다.

세계의 "좌골신경통 치료" 시장 - 주요 동향과 촉진요인 정리

좌골신경통이 세계 의료 시스템에서 주목받는 이유는 무엇인가?

좌골신경의 압박으로 인한 발산성 요통을 특징으로 하는 좌골신경통은 좌식 생활습관, 고령화, 비만율 증가로 인해 점점 더 널리 퍼지고 있습니다. 좌골신경통은 일상적인 이동, 노동 생산성, 삶의 질에 영향을 미칩니다. 이 질환은 생명을 위협하지는 않지만, 장기적인 임상적 치료가 필요한 만성적인 불편함을 초래하는 경우가 많습니다. 사무직 증가와 인체공학의 악화와 함께 인식과 진단의 개선이 좌골신경통 치료에 대한 수요를 주도하고 있습니다. 환자들은 즉각적인 통증 완화와 장기적인 기능 회복을 동시에 달성할 수 있는 맞춤형 치료법을 원하고 있습니다. 이 질환은 자세가 좋지 않은 젊은 층부터 디스크 퇴행성 질환을 앓고 있는 노년층에 이르기까지 다양한 연령층에서 발생하므로 치료법이 빠르게 확대되고 있습니다. 전 세계에서 매년 수백만 명의 사람들이 어떤 형태로든 요통으로 고통받고 있으며, 좌골신경통 관리는 더 넓은 근골격계 질환 시장 내에서 초점으로 떠오르고 있습니다.

치료 프로토콜을 바꾸는 발전은 무엇인가?

기술 혁신은 좌골신경통 치료 시장에 혁명을 가져왔으며, 증상 치료에서 전반적인 회복으로 전환하고 있습니다. 미세 추간판 절제술이나 내시경 척추 수술과 같은 최소 침습 수술은 입원 기간을 단축하고 회복 시간을 개선하고 있습니다. 통증 관리는 영상 유도 주사, 신경 절제술, 척수 자극기 사용으로 강화되고 있습니다. 물리치료는 디지털 물리치료 앱, 웨어러블 모션 센서, AI 기반 자세 교정 시스템을 통해 진화하고 있으며, PRP(혈소판풍부혈장) 및 줄기세포 치료와 같은 재생의료 접근법은 신경과 추간판의 근본적인 손상을 치료하기 위해 인기를 얻고 있습니다. 의약품의 선택 폭도 넓어지고 있으며, 새로운 제제는 서방형 비오피오이드 대체제를 제공합니다. 원격의료는 특히 지방이나 고령의 환자들에게 경과 관찰과 재활을 보다 쉽게 이용할 수 있도록 돕고 있습니다. 이러한 발전을 종합하면 보다 환자 중심적이고 결과 지향적인 치료 경로가 가능해졌습니다.

의료 서비스 프로바이더와 소비자가 시장 역학에 어떤 영향을 미치고 있는가?

환자들의 선호도가 비침습적이고 맞춤 치료 계획으로 바뀌고 있으며, 의료 서비스 프로바이더들은 다학제적 접근법을 채택하고 있습니다. 병원은 신경과, 정형외과, 재활의학과를 통합한 통증 관리 유닛을 구축하고 있습니다. 물리치료, 비수술적 중재 등의 치료에 대한 보험 적용이 확대되어 접근성이 확대되고 있습니다. 소비자 직결형 의료 플랫폼은 환자에게 정보와 자가 관리 툴을 제공하여 치료 선택에 영향을 미치고 있습니다. 신흥 시장에서는 의료 인프라와 가처분 소득 증가로 인해 그동안 간과되었던 만성질환에 대한 치료를 원하는 사람들이 증가하고 있습니다. 의료 서비스 프로바이더 측면에서는 상환 정책 및 증거 기반 치료 가이드라인이 표준 프로토콜을 형성하고 있습니다. 학술기관과 연구 병원들도 새로운 치료법과 디지털 헬스 툴을 시험적으로 도입하여 혁신에 기여하고 있습니다. 의료 프로바이더의 전략과 소비자 행동 사이의 이러한 상호작용은 시장의 반응성을 촉진하는 피드백 루프를 형성하고 있습니다.

좌골신경통 치료 시장의 성장은 여러 가지 요인에 의해 초래됩니다.

시장 성장을 가속하는 몇 가지 연동된 요인이 있습니다. 전 세계에서 허리 질환의 발생률이 증가함에 따라 대규모의 반복적인 환자 기반이 형성되고 있습니다. 진단 및 치료 방법의 기술적 진보로 인해 치료의 효과가 높아져 의료 개입에 대한 환자들의 선호도가 높아지고 있습니다. 침술, 요가, 수처리 등 대체요법이 받아들여지면서 치료 생태계가 다양해지고 있습니다. 인도, 태국 등의 국가에서는 보험 상환 체계가 정비되고 척추 치료를 목적으로 한 의료관광이 증가하면서 새로운 시장이 개발되고 있습니다. 정형외과 전문 클리닉의 확대와 디지털 헬스 스타트업의 진출은 치료를 더욱 친숙하게 만들고 있습니다. 기업의 직원 건강에 대한 관심이 높아짐에 따라 척추 건강을 다루는 직장내 웰니스 프로그램에 대한 수요가 증가하고 있습니다. 이러한 시장 성장 촉진요인들이 복합적으로 작용하여 좌골신경통 치료 시장의 견고한 멀티채널 성장을 보장하고 있습니다.

부문

유형(급성 좌골신경통, 만성 좌골신경통, 기타 유형), 약제 클래스(비스테로이드성 항염증약, 스테로이드, 항우울제, 기타 약제 클래스별), 유통 채널(병원 약국, 소매·전문 약국, 온라인 프로바이더)

조사 대상 기업의 예(주목 44사)

  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Amneal Pharmaceuticals LLC
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Boston Scientific Corporation
  • Bristol Myers Squibb
  • Eliem Therapeutics
  • Endo International plc
  • Glenmark Pharmaceuticals Ltd.
  • Johnson & Johnson
  • Kolon Life Science, Inc.
  • Medtronic plc
  • Novartis AG
  • Pfizer Inc.
  • SCILEX Pharmaceuticals Inc.
  • Seikagaku Corporation
  • Sinfonia Biotherapeutics
  • Sorrento Therapeutics, Inc.
  • Teva Pharmaceutical Industries

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 인위적인 수입원가 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

Global Industry Analysts는 세계 주요 수석 이코노미스트(1,4,949명), 싱크탱크(62개 기관), 무역 및 산업 단체(171개 기관)의 전문가들의 의견을 면밀히 검토하여 생태계에 미치는 영향을 평가하고 새로운 시장 현실에 대응하고 있습니다. 모든 주요 국가의 전문가와 경제학자들이 관세와 그것이 자국에 미치는 영향에 대한 의견을 추적 조사했습니다.

Global Industry Analysts는 이러한 혼란이 향후 2-3개월 내에 마무리되고 새로운 세계 질서가 보다 명확하게 확립될 것으로 예상하고 있으며, Global Industry Analysts는 이러한 상황을 실시간으로 추적하고 있습니다.

2025년 4월: 협상 단계

이번 4월 보고서에서는 관세가 세계 시장 전체에 미치는 영향과 지역별 시장 조정에 대해 소개합니다. 당사의 예측은 과거 데이터와 진화하는 시장 영향요인을 기반으로 합니다.

2025년 7월: 최종 관세 재설정

고객님들께는 각 국가별 최종 리셋이 발표된 후 7월에 무료 업데이트 버전을 제공해 드립니다. 최종 업데이트 버전에는 명확하게 정의된 관세 영향 분석이 포함되어 있습니다.

상호 및 양자 간 무역과 관세의 영향 분석 :

미국 <>중국 <>멕시코 <>캐나다 <>EU <>일본 <>인도 <>기타 176개국

업계 최고의 이코노미스트: Global Industry Analysts의 지식 기반은 국가, 싱크탱크, 무역 및 산업 단체, 대기업, 그리고 세계 계량 경제 상황의 전례 없는 패러다임 전환의 영향을 공유하는 분야별 전문가 등 가장 영향력 있는 수석 이코노미스트를 포함한 14,949명의 이코노미스트를 추적하고 있습니다. 16,491개 이상의 보고서 대부분에 마일스톤에 기반한 2단계 출시 일정이 적용되어 있습니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.06.17

Global Sciatica Treatment Market to Reach US$848.0 Million by 2030

The global market for Sciatica Treatment estimated at US$735.7 Million in the year 2024, is expected to reach US$848.0 Million by 2030, growing at a CAGR of 2.4% over the analysis period 2024-2030. Acute Sciatica Treatment, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$502.4 Million by the end of the analysis period. Growth in the Chronic Sciatica Treatment segment is estimated at 1.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$200.5 Million While China is Forecast to Grow at 4.7% CAGR

The Sciatica Treatment market in the U.S. is estimated at US$200.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$162.7 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 1.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.3% CAGR.

Global "Sciatica Treatment" Market - Key Trends & Drivers Summarized

What Makes Sciatica a Growing Concern in Global Health Systems?

Sciatica, characterized by radiating lower back pain due to compression of the sciatic nerve, is becoming increasingly prevalent due to sedentary lifestyles, aging populations, and rising obesity rates. It impacts daily mobility, workforce productivity, and quality of life. The condition, although non-life-threatening, often results in chronic discomfort requiring prolonged clinical attention. Increased awareness and diagnosis, combined with the rise in desk-based occupations and poor ergonomics, are driving the demand for sciatica treatment. Patients are now seeking personalized therapies that combine immediate pain relief with long-term functional recovery. As the condition spans a broad demographic-from young adults with poor posture to elderly patients with degenerative disc disorders-the treatment landscape is expanding rapidly. With millions globally suffering from some form of lower back pain annually, sciatica management is emerging as a focal point within the broader musculoskeletal disorder market.

What Are the Advancements Reshaping Treatment Protocols?

Technological innovations are revolutionizing the sciatica treatment market, shifting it from symptom management to holistic recovery. Minimally invasive procedures like microdiscectomy and endoscopic spinal surgery are reducing hospital stays and improving recovery times. Pain management has been enhanced through the use of image-guided injections, nerve ablations, and spinal cord stimulators. Physical therapy is evolving with digital physiotherapy apps, wearable motion sensors, and AI-driven posture correction systems. Regenerative medicine approaches, such as PRP (platelet-rich plasma) and stem cell therapy, are gaining traction for addressing underlying nerve or disc damage. Pharmaceutical options are also expanding, with newer formulations offering sustained-release and non-opioid alternatives. Telemedicine has made follow-ups and rehabilitation more accessible, especially in rural and aging populations. Collectively, these advancements are enabling more patient-centric, outcome-oriented care pathways.

How Are Healthcare Providers and Consumers Influencing Market Dynamics?

Patient preferences are shifting toward non-invasive, personalized treatment plans, encouraging providers to adopt multidisciplinary approaches. Hospitals are building integrated pain management units that combine neurology, orthopedics, and rehabilitation. Increasing availability of insurance coverage for therapies like physiotherapy and non-surgical interventions is broadening access. Direct-to-consumer health platforms are empowering patients with information and self-care tools, influencing treatment choices. In emerging markets, rising healthcare infrastructure and disposable incomes are allowing more people to seek treatment for chronic conditions previously overlooked. On the provider side, reimbursement policies and evidence-based treatment guidelines are shaping standard protocols. Academic institutions and research hospitals are also contributing to innovation by piloting novel therapeutics and digital health tools. These interactions between provider strategies and consumer behaviors are forming a feedback loop driving market responsiveness.

The Growth In The Sciatica Treatment Market Is Driven By Several Factors...

Several interlinked factors are propelling market growth. Rising global incidence of lower back disorders is creating a large and recurring patient base. Technological advancements in diagnostics and treatment modalities are increasing care efficacy and patient preference for medical intervention. Growing acceptance of alternative therapies such as acupuncture, yoga, and hydrotherapy is diversifying the treatment ecosystem. Supportive reimbursement frameworks and increasing medical tourism for spinal care in countries like India and Thailand are opening new markets. Expansion of orthopedic specialty clinics and the entry of digital health startups are making treatment more accessible. Increasing focus on employee health by corporates is boosting demand for workplace wellness programs that address spinal health. These combined drivers are ensuring robust, multi-channel growth in the sciatica treatment market.

SCOPE OF STUDY:

The report analyzes the Sciatica Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Acute Sciatica, Chronic Sciatica, Other Types); Drug Class (Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants, Other Drug Classes); Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies, Online Providers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Amneal Pharmaceuticals LLC
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Boston Scientific Corporation
  • Bristol Myers Squibb
  • Eliem Therapeutics
  • Endo International plc
  • Glenmark Pharmaceuticals Ltd.
  • Johnson & Johnson
  • Kolon Life Science, Inc.
  • Medtronic plc
  • Novartis AG
  • Pfizer Inc.
  • SCILEX Pharmaceuticals Inc.
  • Seikagaku Corporation
  • Sinfonia Biotherapeutics
  • Sorrento Therapeutics, Inc.
  • Teva Pharmaceutical Industries

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Sciatica Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Sedentary Lifestyles and Aging Populations Propel Demand for Sciatica Treatments
    • Increasing Adoption of Non-Invasive Pain Management Therapies Strengthens Market for Physical Rehabilitation
    • Expanding Use of Spinal Injections and Nerve Block Techniques Throws the Spotlight on Interventional Treatments
    • Growth in Chiropractic and Alternative Therapies Fuels Demand for Integrated Pain Management Solutions
    • Rising Awareness of Early Diagnosis and Lifestyle Correction Sustains Market for Conservative Therapies
    • Surgical Innovations in Microdiscectomy and Minimally Invasive Techniques Drive Treatment Uptake
    • Workplace Wellness Programs Accelerate Demand for Preventive and Therapeutic Services
    • Expansion of Telemedicine and Virtual Physical Therapy Platforms Broadens Patient Access
    • Advances in Wearable Posture and Mobility Devices Support Sciatica Self-Management
    • Increasing Insurance Coverage for Physical Therapy and Pain Management Boosts Adoption
    • Cross-Specialty Collaboration Creates Multidisciplinary Treatment Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sciatica Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sciatica Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sciatica Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Sciatica Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Acute Sciatica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Acute Sciatica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Acute Sciatica by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chronic Sciatica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Chronic Sciatica by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Chronic Sciatica by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Online Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Online Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Online Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Retail & Specialty Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Retail & Specialty Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Retail & Specialty Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Non-Steroidal Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Non-Steroidal Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Non-Steroidal Anti-Inflammatory Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Steroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Steroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Steroids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Antidepressants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Antidepressants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Antidepressants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Drug Classes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • JAPAN
    • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • CHINA
    • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • EUROPE
    • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Sciatica Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Sciatica Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Sciatica Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • FRANCE
    • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • GERMANY
    • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Sciatica Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Sciatica Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Sciatica Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • INDIA
    • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Sciatica Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Sciatica Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Sciatica Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Sciatica Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Sciatica Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Sciatica Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030
  • AFRICA
    • Sciatica Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Sciatica Treatment by Type - Acute Sciatica, Chronic Sciatica and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Sciatica Treatment by Type - Percentage Breakdown of Value Sales for Acute Sciatica, Chronic Sciatica and Other Types for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Sciatica Treatment by Distribution Channel - Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Sciatica Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Online Providers, Hospital Pharmacies and Retail & Specialty Pharmacies for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Sciatica Treatment by Drug Class - Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Sciatica Treatment by Drug Class - Percentage Breakdown of Value Sales for Non-Steroidal Anti-Inflammatory Drugs, Steroids, Antidepressants and Other Drug Classes for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제